Octapharma Australia Pty Limited

ABN: 23109574692

Enterprise ($50M+)

$329.7M

Total Value

1

Total Contracts

Drugs and Pharmaceutical

Primary Category

Recent Contracts

Active

Drugs and Pharmaceutical

4 Sept 2025

CN3743079—National Supply arrangement for imported immunoglobulin products$329.7M

31 Dec 2020 - 30 Dec 2027

National Blood Authority

Retender Opportunities

10 expiring contracts in this supplier's categories that may be retendered soon.

28d until expiry

Category + Value

Drugs and Pharmaceutical

CN4164112—Supply of Essential Vaccines to the National Immunisation Program$431.2M

Current: GlaxoSmithKline Australia Pty Ltd Department of Health, Disability and Ageing

28d until expiry

Category + Value

Drugs and Pharmaceutical

CN4166714—Supply of Essential Vaccines to the National Immunisation Program$118.5M

Current: Pfizer Australia Pty Ltd Department of Health, Disability and Ageing

28d until expiry

Category + Value

Drugs and Pharmaceutical

CN4164115—Supply of Essential Vaccines to the National Immunisation Program$100.0M

Current: Seqirus (Australia) Pty Ltd Department of Health, Disability and Ageing

Unlock 10 retender opportunities

See contract values, current suppliers, and exact expiry dates.

Peer Benchmarking

See how Octapharma Australia Pty Limited ranks against similar companies in their category and size band.

Financial Year Breakdown

FY21

$329.7M(1 contracts)

Company Details

Name: Octapharma Australia Pty Limited
Entity Type: Australian Private Company
ABN: 23 109 574 692
ACN: 109 574 692
Status: Registered
Registered: 30 June 2004
Town/City: Lachen
Postcode: 8853
Country: SWITZERLAND